论文部分内容阅读
提起放开医药小商品,人们总有种种议论,或曰放得太少,或曰放而不活.总之议论多于行动.浙江省兰溪制药厂却不是停留在议论上,而是用足政策,在实干中搞活了企业.该厂是一家生产中成药的老厂,年生产品种100余种,其中将近一半是“榜上无名”的小字辈成药.小成药定价权未放给生产企业之前,生产的小品种逐年减少,产值、效益也同步下降.到1988年小成药仅生产9个品种,产量4000多公斤,产值10万余元,占总产值不
When people talk about the release of pharmaceutical products, people always have all sorts of arguments, or they put too little on them, or they put them on rather than live. In short, there is more discussion than action. Lanxi Pharmaceutical Factory in Zhejiang Province does not stop at the discussion, but uses the full policy. The company has invigorated the enterprise. This factory is an old factory that produces proprietary Chinese medicines. It produces more than 100 varieties each year, nearly half of which are small-size medicines on the list. Prior to the pricing of small-scale medicines, they were not released to production companies. The production of small varieties has been reduced year by year, and the output value and benefits have also dropped. By 1988, Xiaocheng Pharmaceutical had produced only 9 varieties, the output was over 4,000 kilograms, and the output value was more than 100,000 yuan, which did not account for the total output value.